Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl‑kinase inhibitor targeting colon cancer

Rodrigues, Fiona C and Hari, Gangadhar and Pai, K S R and Suresh, Akhil and Nayak, Usha Y and Anil Kumar, N V and Thakur, Goutam (2021) Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl‑kinase inhibitor targeting colon cancer. 3 Biotech, 11 (506). ISSN 2190-572X

[img] PDF
13937.pdf - Published Version
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

The human Abl kinases comprise a family of proteins that are known to be key stimulus drivers in the signaling pathways modulating cell growth, cell survival, cell adhesion, and apoptosis. Recent collative studies have indicated the role of acti�vation of Abl and Abl-related genes in solid tumors; further terming the Abl kinases as molecular switches which promote proliferation, tumorigenesis, and metastasis. The up-regulated Abl-kinase expression in colorectal cancer (CRC) and the role of Abl tyrosine kinase activity in the Matrigel invasion of CRC cells have cemented its signifcance in CRC advancement. Therefore, the requisite of identifying small molecules which serve as Abl selective inhibitors and designing anti-Abl thera�pies, particularly for CRC tumors, has driven this study. Curcumin has been touted as an efective inhibitor of cancer cells; however, it is limited by its physicochemical inadequacies. Hence, we have studied the behavior of heterocyclic derivatives of curcumin via computational tools such as pharmacophore-based virtual screening, molecular docking, free-energy binding, and ADME profling. The most actively docked molecule, 3,5-bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-carboxamide, was comparatively evaluated against Curcumin via molecular dynamics simulation using Desmond, Schrödinger. The study exhibited the improved stability of the derivative as compared to Curcumin in the tested protein pocket and displayed the interaction bonds with the contacted key amino acids. To further establish the claim, the derivatives were synthesized via the mechanism of cyclization of Curcumin and screened in vitro using SRB assay against human CRC cell line, HCT 116. The active derivative indicated an IC50 value of 5.85 µM, which was sevenfold lower as compared to Curcumin’s IC50 of 35.40 µM. Hence, the results base the potential role of the curcumin derivative in modulating Abl-kinase activity and in turn may have potential therapeutic value as a lead for CRC therapy

Item Type: Article
Uncontrolled Keywords: Abl kinase · Colorectal cancer · Curcumin · Heterocyclic · Molecular docking · Molecular dynamics
Subjects: Engineering > MIT Manipal > Biomedical
Engineering > MIT Manipal > Chemistry
Pharmacy > MCOPS Manipal > Pharmaceutics
Depositing User: MIT Library
Date Deposited: 20 Jan 2022 06:04
Last Modified: 20 Jan 2022 06:04
URI: http://eprints.manipal.edu/id/eprint/158076

Actions (login required)

View Item View Item